Haleon (HLN) Total Non-Current Liabilities (2021 - 2025)

Haleon (HLN) recorded quarterly Total Non-Current Liabilities of $14.9 billion in Q4 2025, down 5.36% on a QoQ basis from $15.8 billion in Q4 2024, and down 5.36% year-over-year from $15.8 billion in Q4 2024.

Haleon (HLN) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Haleon has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $14.9 billion for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 5.36% year-over-year to $14.9 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.9 billion (down 5.36% YoY) and the FY2025 annual result came in at $14.8 billion, down 5.81% from the prior year.
  • Total Non-Current Liabilities declined to $14.9 billion in Q4 2025, from $15.8 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $16.4 billion in Q4 2022 and troughed at -$17.4 billion in Q2 2022.
  • A 5-year average of $2.6 billion and a median of $10.0 billion in 2021 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 226.04% — and 2025, when it slipped 5.36%.
  • Tracing HLN's Total Non-Current Liabilities over 5 years: stood at $5.0 billion in 2021, then surged by 226.04% to $16.4 billion in 2022, then retreated by 4.03% to $15.7 billion in 2023, then increased by 0.09% to $15.8 billion in 2024, then decreased by 5.36% to $14.9 billion in 2025.
  • Business Quant data shows HLN's Total Non-Current Liabilities at $14.9 billion in Q4 2025, $15.8 billion in Q4 2024, and -$14.0 billion in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 18.28 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 2.44 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 1.81 Bn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 1.13 Bn
10 Haleon 1.09 Bn -773.69 Mn - 14.92 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.92 Bn
Dec 31, 2024 15.76 Bn
Jun 30, 2024 -13.97 Bn
Dec 31, 2023 15.75 Bn
Jun 30, 2023 -15.78 Bn
Dec 31, 2022 16.41 Bn
Jun 30, 2022 -17.39 Bn
Dec 31, 2021 5.03 Bn